Pages that link to "Q44611165"
Jump to navigation
Jump to search
The following pages link to Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes (Q44611165):
Displaying 50 items.
- Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis (Q26738743) (← links)
- Potential role for metformin in urologic oncology (Q26747759) (← links)
- Mechanistic Insights into Molecular Targeting and Combined Modality Therapy for Aggressive, Localized Prostate Cancer (Q26766638) (← links)
- Biomarkers of cancer angioprevention for clinical studies (Q26774580) (← links)
- Obesity and cancer: mechanistic insights from transdisciplinary studies (Q26786829) (← links)
- Metabolic syndrome and diabetes for the urologist (Q26830106) (← links)
- Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis (Q28074225) (← links)
- Dissecting the Dual Role of AMPK in Cancer: From Experimental to Human Studies (Q28081491) (← links)
- Nutrition, dietary interventions and prostate cancer: the latest evidence (Q28084566) (← links)
- Novel non-AR therapeutic targets in castrate resistant prostate cancer (Q28383663) (← links)
- Effect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studies (Q28542914) (← links)
- MATE2 Expression Is Associated with Cancer Cell Response to Metformin (Q28555000) (← links)
- Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing? (Q30242051) (← links)
- Metformin effects on biochemical recurrence and metabolic signaling in the prostate (Q30665188) (← links)
- Associations among Metabolism, Circadian Rhythm and Age-Associated Diseases (Q33714257) (← links)
- Type 2 Diabetes Mellitus and Cancer: The Role of Pharmacotherapy (Q33756414) (← links)
- Prostate cancer progression and mortality: a review of diet and lifestyle factors (Q33802558) (← links)
- Poor glycemic control of diabetes mellitus is associated with higher risk of prostate cancer detection in a biopsy population (Q34149590) (← links)
- Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes (Q34323510) (← links)
- Metformin in cancer prevention and therapy (Q34357983) (← links)
- Molecular pathways and targets in prostate cancer (Q34365632) (← links)
- Diabetes, prediabetes and the survival of nasopharyngeal carcinoma: a study of 5,860 patients (Q34414818) (← links)
- Is pathology necessary to predict mortality among men with prostate-cancer? (Q34769040) (← links)
- The biology of castration-resistant prostate cancer (Q35039889) (← links)
- Serum glucose and risk of cancer: a meta-analysis (Q35059999) (← links)
- Highlights of the university of toronto urology update 2014. (Q35100023) (← links)
- Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy (Q35149589) (← links)
- Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity (Q35176093) (← links)
- Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series (Q35226909) (← links)
- Impact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis (Q35558619) (← links)
- Effect of metformin on progression of head and neck cancers, occurrence of second primary cancers, and cause-specific survival (Q35586709) (← links)
- Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients (Q35620994) (← links)
- Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study (Q35952232) (← links)
- Determinants of mortality in patients with type 2 diabetes: a review (Q35986709) (← links)
- Axl receptor tyrosine kinase is up-regulated in metformin resistant prostate cancer cells (Q36021012) (← links)
- Metformin-induced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells (Q36021086) (← links)
- Metformin inhibits hepatocellular glucose, lipid and cholesterol biosynthetic pathways by transcriptionally suppressing steroid receptor coactivator 2 (SRC-2). (Q36262595) (← links)
- Metformin use and risk of prostate cancer: results from the REDUCE study (Q36296255) (← links)
- Metformin represses cancer cells via alternate pathways in N-cadherin expressing vs. N-cadherin deficient cells (Q36557189) (← links)
- Metformin Protects Against Cisplatin-Induced Tubular Cell Apoptosis and Acute Kidney Injury via AMPKα-regulated Autophagy Induction (Q36774352) (← links)
- The effect of statins on prostate cancer recurrence and mortality after definitive therapy: a systematic review and meta-analysis (Q37072692) (← links)
- Preventive Effects of Fermented Brown Rice and Rice Bran against Prostate Carcinogenesis in TRAP Rats (Q37133065) (← links)
- The Association between Treatment for Metabolic Disorders and Breast Cancer Characteristics. (Q37246561) (← links)
- The Relationship Between Metformin and Serum Prostate-Specific Antigen Levels (Q37316486) (← links)
- Vasectomy and risk of prostate cancer: population based matched cohort study (Q37391194) (← links)
- Metformin inhibits androgen-induced IGF-IR up-regulation in prostate cancer cells by disrupting membrane-initiated androgen signaling (Q37648017) (← links)
- Association between metformin use and mortality in patients with type 2 diabetes mellitus and localized resectable pancreatic cancer: a nationwide population-based study in korea (Q37706025) (← links)
- Marriage is a dependent risk factor for mortality of colon adenocarcinoma without a time-varying effect (Q37746233) (← links)
- Studying cancer treatment in the elderly patient population (Q38222468) (← links)
- Glioma stem cells: markers, hallmarks and therapeutic targeting by metformin (Q38244345) (← links)